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Periodontal disease is characterized by a chronic inflammation produced in response to a 
disease-associated, multispecies bacterial community in the subgingival region. In recent years, 
interest has focused on the potential role of periodontal disease in cancer pathogenesis. In this 
review, we presented a summary showing a strong association between breast cancer and poor 
oral health, presence of periodontitis-associated bacteria, tooth loss, and clinical signs of 
periodontitis. Proinflammatory pathways are activated either by mono- or polymicrobial 
infections, resulting in an increase in the expression of proinflammatory molecules such as 
interleukin (IL)-6, IL-8, IL-1β, and tumor necrosis factor (TNF)-α. In addition, it has been shown 
that several periodontitis-associated species induce the expression of genes related to cell 
proliferation, cell cycle, apoptosis, transport, and immune and inflammatory responses. 
Intriguingly, many of these pathways are linked to carcinogenesis. Among them, the activation 
of Toll-like receptors (TLRs) and antiapoptotic pathways (such as the phosphoinositide-3-kinase-
protein kinase B/Akt [PI3K-PKB/Akt], Janus kinase/signal transducers and activators of 
transcription [JAK/STAT], and mitogen-activated protein kinase [MAPK] pathways), the 
reduction of proapoptotic protein expression, the increase in cell migration and invasion, and the 
enhancement in metastasis are addressed. Cigarette smoking is one of the major causes of 
carcinogenesis. The incidence of breast cancer is increasing worldwide, making it the most 
common type of cancer among women. The etiology of breast cancer is multifactorial and 
cigarette smoking is one of the risk factors that has recently been shown to be associated with 
breast cancer. The relationship between cigarette smoking and breast cancer is due to one of 
the important components of cigarette smoke, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone 
(NNK), which is a representative carcinogen of N-nitrosamines that has gained focus in breast 
cancer carcinogenesis. The purpose of this review is to investigate the relationship between 
breast cancer and chronic periodontal disease changes that can occur at the oral level, including 
alterations of the oral microbiome, and pathological conditions among postmenopausal female 
smokers. Chronic periodontal disease and tooth loss were highly prevalent in postmenopausal 
breast cancer survivors. Based on this traditional review, the importance of dentists is clear in 
proposing to patients with breast cancer appropriate therapies and dedicated prevention 
sessions. 
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Introduction 
It is now proven that periodontal diseases 
are associated with systemic conditions. The 
interactions that develop between 
periodontal bacteria and the oral cavity are 
multiple and very complex. More than 120 
medical conditions, some of which are life 
threatening, can be detected and treated in 
the early stages by periodontists.1 There is a 
growing body of evidence suggesting a 
relationship between periodontal disease, 
cigarette smoking, and increased breast 
cancer risk. 
Periodontal disease is characterized 
by a chronic inflammation produced in 
response to a disease-associated 
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multispecies bacterial community in the 
periodontium.2 Although the inflammatory 
processes occur locally in the oral cavity, 
several studies have determined that 
inflammatory mediators produced during 
periodontitis, as well as subgingival species 
and bacterial components, can disseminate 
from the oral cavity, therefore contributing to 
various extra-oral diseases such as cancer.3 
Interestingly, cancers are highly influenced 
by both a direct carcinogenic effect of 
periodontitis-associated bacteria in either 
oral cells or in other body sites and 
inflammatory mediators migrating from the 
oral cavity.4 However, although increasing 
evidence links periodontitis and 
carcinogenesis, the fact that periodontitis is 
a polymicrobial disease has not been well 
addressed in the context of cancer.5 This is 
especially relevant when evaluating the 
direct carcinogenic effect exerted by oral 
bacteria, since combined species act locally 
in oral cells and also migrate from the oral 
cavity. Cancer is a leading cause of mortality 
worldwide and among the female-specific 
malignancies, breast cancer remains the 
most common cancer type in developed 
countries, accounting for one-third of newly 
diagnosed cancers.6 The incidence of breast 
cancer was registered from 1985 to 2001 
according to the World Health Organization 
(WHO) International Classification of 
Diseases criteria. In the present review, I am 
reporting a strong association between 
breast cancer and poor oral health, presence 
of periodontitis-associated bacteria, tooth 
loss, and clinical signs of periodontitis. 
In 2013, the WHO estimated that 
globally, 21% of adults were current 
smokers, including 250 million women and 1 
billion men.7 Women account for 15.7% of all 
current smokers, most of whom live in mid- 
and low-income countries. The WHO has 
also estimated that smoking is the cause of 
death of about six million people each year.8 
The current available knowledge about the 
relationship between some certain human 
cancers and smoking is based mainly on 
epidemiological studies. Not until recently 
has the association between cigarette 
smoke and breast cancer received much 
attention. Many epidemiological and 
preclinical studies have implicated that 
cigarette smoke is one of the risk factors for 
breast cancer.9 Cigarette smoke contains 
more than 4,000 components, of which over 
70 have been classified as carcinogens by 
the International Agency for Research on 
Cancer (IARC).10 Several tobacco 
carcinogens that have been detected in the 
circulation of smokers are activated and 
metabolized into electrophilic intermediates 
by breast epithelial cells because of DNA 
adduct formation and DNA damage.11 Thus, 
much attention has been extended to breast 
cancer. 
The purpose of the present review is 
to investigate the link between smokers’ 
breast cancer and the periodontal disease 
changes that can occur at the oral level, 
including alterations of the oral microbiome 
and pathological conditions. The focus of 
this traditional review is on the 
epidemiological, biological, systemic, and 
genetic evidence that has accumulated 
particularly over the past decade, which 
supports a causal mechanism between 
periodontal disease and smokers’ breast 
cancer. 
The Link Between Periodontal Disease 
and Cancer 
Several epidemiological and laboratory 
studies have reported that long-term 
inflammation promotes tumor development, 
growth, and progression.12 It has been 
confirmed that malignancies can arise from 
areas that are characterized by infection and 
inflammation as a part of the physiological 
immune response of the host. This 
observation suggests that chronic 
inflammation could be a risk factor for the 
development of a number of malignancies in 
humans, including in organs such as the 
breast.13 Persistent host infections are able 
to induce chronic inflammation in which 
leukocytes and other immune system 
phagocytes can induce DNA damage in 
proliferating cells through the production of 
toxic substances such as reactive oxygen 
species (ROS) and reactive nitrogen 
intermediates (RNI) that under normal 
conditions are produced by those cells for 
the control of the infection.14 These species 
react to the formation of peroxynitrate which 
is a mutagenic agent. Consequently, a re-
peated tissue injury and the regeneration of 
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the damaged tissue in the presence of 
elevated levels of ROS and RNI released by 
inflammatory cells, causing those reactive 
species to be involved in oxidative DNA 
damage in proliferating epithelial cells 
leading to permanent alterations in the 
genome, such as point mutations, 
chromosomal deletions, or rear-
rangements.14 
The link between inflammatory 
response and cancer has been considered 
to consist of two mechanisms, an exogenous 
and an endogenous. According to the 
exogenous mechanism, a chronic 
inflammatory response is able to increase 
the risk of cancer, while in the endogenous, 
acquired genetic alterations can trigger 
tumor development and growth.15 Chronic 
inflammation can stimulate the development 
of malignant tumors of epithelial origin due to 
an indirect mechanism that involves the 
activation of local inflammatory cells. This 
process can also lead to the exposure of 
proliferating epithelial cells to mutagen 
factors. Microorganism products that relate 
to inflammation are able to activate host 
cells, such as inflammatory response cells, 
tissue fibroblasts, and epithelial cells to 
produce a wide spectrum of toxic 
substances that are able to cause damage 
to the epithelial cell DNA. Chronic 
inflammatory responses are often 
associated with the release of large amounts 
of cell substances such as chemokines, 
growth factor agents, cytokines, and other 
species that can create a suitable 
environment for cellular survival, cell 
proliferation and migration, promotion of 
angiogenesis, and inhibition of apoptosis. 
This environment can cause the epithelial 
cells to accumulate mutations and lead 
those mutant cells to proliferate and migrate 
and can provide opportunities for the 
development and growth of those cells.16 
The highest incidence of cancer being in 
individuals with chronic inflammation was 
the basis for investigating the probability of 
correlation with periodontitis.17  
The Specific Role of Periodontal Disease 
in the Pathogenesis of Breast Cancer in 
Smokers 
The association is biologically possible and 
could be interpreted on the basis of the 
following mechanisms:18  
a. The disrupted mucosal barrier in cases of 
periodontal disease causes an enhanced 
carcinogen penetration, as with smoking. 
b. The cell load increases in the blood 
vessels and the connective tissue in case of 
a chronic inflammatory response. The 
relationship between chronic inflammation 
and cancer is associated with the 
development of a chronic diffuse hyperplasia 
of the epithelial cells that is considered a 
common precursor of intraepithelial 
neoplasia. 
c. Immunosuppression is a common 
mechanism that leads to periodontal disease 
and cancer. 
d. A bacterial overgrowth may occur due to 
poor oral hygiene leading to an increase in 
the percentage of metabolites with a 
potential carcinogenic effect. 
e. With common genetic risk factors, such as 
in dizygotic twins, the classic periodontal 
disease leads to a significantly increased 
risk for cancer development, whereas in 
monozygotic twins this association is 
significantly impaired.19 
The Mechanism of Cancer Promotion by 
Periodontitis-Associated Bacteria 
Although the exact mechanisms involved in 
cancer promotion by periodontal bacteria 
have not been completely elucidated, local 
inflammatory effects triggered by bacterial 
infection have been associated with cellular 
transformation (Figure 1).5,20 
Hypotheses on the Relationship Between 
Periodontal Disease and Cancer 
A. Alteration in Oral Microflora 
From a periodontal point of view, a wide 
variety of oral microorganisms, oral bacteria, 
and their metabolic products, such as 
endotoxins and enzymes that are toxic to the 
surrounding cells and tissues, may directly 
induce mutations in tumor suppressor genes 
and proto-oncogenes or alter cellular 
signaling pathways that affect epithelial cell 
survival or cellular proliferation (Figure 
2).21,22 
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B. Periodontitis, Inflammatory Load, and 
Predisposition for Carcinogenesis 
Periodontitis causes the release of 
cytokines, chemokines, prostaglandins 
(PGs), bacterial toxins, endotoxins, and 
enzymes from the host’s cells which have 
destructive effects on periodontal tissue 
including periodontal pocket formation and 
alveolar bone destruction.23 
Proinflammatory cytokines such as tumor 
necrosis factor (TNF)-α, interleukin (IL)-1β, 
interferon (IFN)-γ and PGE2 are present in 
elevated levels in periodontitis. Periodontal 
tissue may act as a refreshment tank for the 
leakage of those mediators causing them to 
enter the blood circulation leading to 
systemic effects.24 
A link between periodontal disease 
and cancer has been recorded in a 
population of health professionals and the 
conclusion was that the mechanisms that 
are associated with the inflammatory load 
due to systemic inflammation, and the 
increased concentrations of carcinogenic 
products subsequent to inflammatory 
processes in response to the oral 
pathogens, could contribute to the 
development of cancer.25 Periodontitis may 
be a substitute indicator for the effects of 
smoking. It is relevant that cigarette smoking 
is responsible for oxidative stresses and 
activates processes that could contribute to 
epithelial cell transformation, whereas the 
degree of periodontal inflammatory load 
would be an important factor in triggering a 
systemic effect (Figure 3).26,27
 
Figure 1. Host response mechanisms of cellular transformation induced by periodontopathic 
bacteria 
 
Inhibition of apoptosis, epithelial-mesenchymal transition (EMT), invasion and migration, metastasis, and 
proliferation are triggered through the activation of prooncogenic pathways by P. gingivalis (red arrows), 
T. denticola (green arrow), F. nucleatum (blue arrow), and P. gingivalis + F. nucleatum coinfection (purple 
arrows).
 
C. Genetic Factors 
Common underlying genetic factors may 
increase the host’s susceptibility to both 
periodontal disease and cancer or may alter 
the relationship of environmental factors, 
such as smoking, with both conditions. 
However, the common genetic risk factors’ 
role between the two conditions remains 
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unclear. Predetermined factors such as 
genetic polymorphisms could be involved in 
the sensitivity of the disease. As has already 
been reported, an inflammatory response 
may play a role in some cancers, and it is 
possible that the genetic polymorphisms that 
are related to an increased periodontal 
disease risk are also of vital importance in 
cancer development (Figure 4).28,29
 
Figure 2. An outline of NNK-induced signaling pathways 
 
Prevalence of Breast Cancer 
Breast cancer is the most common 
malignancy in women worldwide and the 
leading cause of death among women.30 
According to recent estimates, 1.38 million 
women were diagnosed with breast cancer 
and 485,000 died worldwide in 2019.31 
Breast cancer is one of the most frequently 
diagnosed cancers among women in 
economically developing countries.32 In the 
year 2020 more than 1.5 million new cases 
of breast cancer have been reported globally 
and the incidence has increased by 20.0%.33 
In a cancer research, it was reported that 
women from the United Kingdom and the 
United States were observed to be at a 
higher risk, with a rate of more than 120 per 
100,000 population.34 In contrast, India, 
China, and South Africa have a considerably 
lower incidence rate of about 30 per 100,000 
population. Overall, a five year survival rate 
is observed among 80-90% of patients from 
the United Kingdom and the United States 
and is only up to 50-60% among patients 
from India, Thailand, and Malaysia.35 In 
India, breast cancer is the most common 
cancer diagnosed among women, 
accounting for nearly 1 in 3 cancers, and is 
the second leading cause of cancer death 
among women after lung cancer.7 Over 
200,000 women are diagnosed with breast 
cancer annually in India. Breast cancer 
occurs more frequently in postmenopausal 
women at the age of 61 years. Although the 
etiology of most breast cancers is unknown, 
some risk factors have been established 
such as gender, age, family history, late 
menopause, early menarche, ethnicity, and 
genetic risk factors.36 On the other hand, an 
important decrease in mortality due to breast 
cancer has been observed in recent years 
due to the development of new adjuvant 
therapy and screening programs.37 As 
breast cancer is undoubtedly a very serious 
and widespread problem, it is important to 
evaluate if there is a correlation between oral 
diseases and this type of tumor as a means 
of further defence against this pathological 
condition. 
The Relationship Between Periodontitis 
and Breast Cancer 
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Periodontal disease is characterized by 
chronic infection and inflammation of 
periodontal tissue leading to the destruction 
of alveolar bone surrounding the teeth. The 
relationship between periodontitis and 
breast cancer has been widely investigated 
through several works. 
In 2011, Soder et al. conducted a 
prospective study of 3,273 women randomly 
selected between the ages of 30 and 40 
years for a period of approximately 16 years. 
The study showed that women with 
periodontitis and with missing molars had a 
higher risk of developing breast cancer.16 
Figure 3. Flow chart explaining the mechanism of cancer progression from 












Figure 4. Flow chart summarizing the simplified molecular mechanism of cancer progression by 
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Virtanen et al. examined the 
association between periodontitis and breast 
cancer risk in 2009 and found that 6.3% of 
the 286 recruited subjects with periodontal 
disease also had cancer. Moreover, it was 
observed that the risk of cancer was greater 
if the first mandibular molar was missing, 
compared to the second mandibular molar.38 
This association also seems to have been 
confirmed through a study by Freudenheim 
et al. who reported an increased risk of 
breast cancer among more than 93,000 
postmenopausal women with a history of 
periodontitis, especially in former smokers 
who quit in the previous 20 years.39 
Sfreddo et al. also reported a link 
between periodontitis and breast cancer in a 
sample of adult Brazilian women. They 
observed that cases had significantly greater 
clinical attachment loss than controls. 
Women diagnosed with periodontitis had two 
to three times higher odds of breast cancer 
than women without periodontitis. They 
concluded that a significant association was 
observed between periodontitis and breast 
cancer.40 
Shi et al. conducted a meta-analysis 
of 8 studies which included 168,111 subjects 
and explored the connection between 
periodontal disease and breast cancer. They 
showed that periodontal disease did 
increase susceptibility to breast cancer with 
robust results confirmed by sensitivity 
analysis (RR = 1.18, CI 95%: 1.11–1.26).41 
In another systematic review, Nwizu 
et al. initially examined just under 500 
articles to understand the role of 
periodontitis in cancer development in 
various sites, including breast cancer. An 
association was found between periodontal 
disease and the breast neoplasms (RR = 
1.11; CI 95%: 1.00-1.23).42 
Amodio et al. conducted a case-
control study in which they assessed the 
prevalence of periodontal disease in 48 
postmenopausal patients following cancer 
treatment, compared to 48 controls without 
cancer. They detected a high prevalence of 
periodontitis in postmenopausal survivors 
(98% in breast cancer survivors and 87% in 
controls). The results found are therefore 
oriented in two directions; on the one hand, 
patients with periodontitis had an an 
increased risk of developing breast cancer, 
and on the other hand, a greater prevalence 
of periodontitis was observed in treated 
cancer patients.43 
A possible explanation is that 
periodontal disease is associated with an 
increased production of reactive oxygen 
species which cause damage to the host 
cells and tissues. The by-products of the oral 
inflammation enter the bloodstream, which 
may enhance cellular proliferation and 
mutagenesis and allow for the development 
and spread of cancer. Some studies have 
also described that some polymorphisms of 
Toll-like receptor (TLR) genes are 
associated with not only a greater 
susceptibility to periodontitis, but to several 
types of cancer as well.44 It is opportune to 
observe how the lowering of the immune 
defences due to cancer and its treatments 
can be a factor favouring the development of 
periodontal disease. 
 
Association of Cigarette Smoking with 
Breast Cancer Risk 
To clarify our understanding of the 
relationship between cigarette smoking and 
breast cancer risk we examined the 
association using data from the National 
Institutes of Health (NIH) study, a large 
prospective cohort study that has previously 
demonstrated breast cancer risk 
relationships for a variety of factors that 
could potentially confound or modify 
associations with cigarette smoking.45 
Additionally, we examined whether smoking 
was related to the risk of specific subgroups 
of breast cancer, defined by disease stage at 
diagnosis, histology, hormone receptor 
expression, and tumor grade. 
Many epidemiological studies have 
revealed an association between smoking 
and breast cancer risk among women. 
Reynolds and Cui have demonstrated that 
breast cancer incidence was associated with 
cigarette smoking.46,47 A positive correlation 
between breast cancer risk and active 
cigarette smoking was observed, and 
current smokers had a higher risk of breast 
cancer than former smokers. Among them, 
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those who smoked for more than 40 years 
showed a significant association with 
increased breast cancer risk than those who 
had a history of smoking for a smaller 
number of years. In 2005, the California 
Environmental Protection Agency (CaEPA) 
reviewed 52 studies and concluded that 
there was a positive correlation of breast 
cancer risk with active cigarette smoking.48 
Furthermore, cigarette smoke also 
increased the risk of breast cancer among 
women who were postmenopausal.  
The Possible Biological Mechanisms 
Explaining How Cigarette Smoking 
Increases the Risk of Breast Cancer 
Among Postmenopausal Women 
The association of smoking with increased 
risk of breast cancer is biologically plausible, 
especially when exposure occurs during 
certain critical periods. Pubertal breast 
development generally begins prior to 
menarche and marks a time of increased 
epithelial cell proliferation. As such, this may 
be a critical time for susceptibility to 
carcinogens. Other investigations point 
towards the importance of the timing of 
smoking initiation in relation to reproductive 
development. Women who are 
BRCA1/BRCA2 mutation carriers at high risk 
of a specific type of familial breast cancer, 
which is consistent with the finding of 
smoking-associated risk among 
postmenopausal women.49 The potential 
mechanism that would result in a smoking-
associated risk among these women could 
be hypothesized by the fact that smoking 
and a  family history of breast cancer 
contribute to risk through the same pathway, 
and if that pathway is activated by factors 
like family history there can be further 
activation by smoking. A greater exploration 
of the role of genetic factors in smoking 
associated breast carcinogenesis is needed 
to understand the possible effect of 
modification by family history. 
Human biomarker studies have also 
strongly suggested that breast tissue is a 
target for the carcinogenic effects of 
cigarette smoke.50 It was found that DNA 
adducts (DNA covalently bonded to a 
carcinogenic chemical) with derivatives of 
cigarette smoke are more common in the 
breast tissue of smokers than that of non-
smokers.51 The wide variation between 
people in DNA adduct formation and repair 
is likely related to a combination of factors, 
including the properties of individual 
carcinogens and host genetic 
polymorphisms.52 In 1996, Ambrosone et al. 
reported that postmenopausal women who 
smoked and had the slow acetylator 
genotype for N-acetyltransferase 2 (NAT 2) 
had a significantly elevated risk for breast 
cancer.53 
Breast cancer is a heterogeneous 
disease that may vary in its etiologies. 
Current data suggest that cigarette smoking 
is more strongly associated with lobular 
cancer than with ductal cancer and with 
tumors that are hormone receptor positive 
for both estrogen and progesterone than the 
other three combinations of receptor status. 
One study that examined smoking in relation 
to the risk of different histological subtypes 
of breast cancer among postmenopausal 
women reported that recent smoking had a 
borderline association with the risk of ductal 
cancer (odds ratio 1.2 [95% confidence 
interval 1.0 to 1.4]) but not with other 
histological types.54 The findings suggesting 
a particular association with lobular cancer 
should be considered preliminary.  
The relationship between cigarette 
smoking and breast cancer is due to one of 
the important components of cigarette 
smoke, 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanone (NNK), which is a representative 
carcinogen of N-nitrosamines. Moreover, it 
has been suggested that cigarette smoking 
plays a role in contributing to DNA 
alterations in postmenopausal breast cancer 
patients. Although increasing evidence 
points to the potentiating effect of cigarette 
smoking on the development of breast 
cancer, there are still some controversies on 
its significance.55 
The Active Component in Cigarette 
Smoke is NNK 
More than 60 known carcinogens have been 
identified in cigarette smoke, among which 
nicotine-derived nitrosamine ketones (NNK) 
have gained much attention in cancer 
initiation and promotion.56 In fact, the IARC 
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has classified NNK as a carcinogen in 2007. 
The level of NNK varies in different cigarette 
brands and it ranges from 53.5-220.7 
ng/cigarette in mainstream smoke and 50.7-
96.7 ng/cigarette in sidestream smoke.10 
Among all tobacco-specific nitrosamines, 
NNK has been proven to cause lung cancer 
in humans and animals.56  
The Effect of NNK in Breast Cancer 
Progression 
The effect of NNK on breast cancer initiation 
has been studied in normal breast cells. 
Treatment with NNK on breast epithelial cell 
line MCF-10A showed malignant 
transformation with over expression of α7- 
and α9-nicotinic acetylcholine receptors 
(nAChRs). NNK upregulated extracellular 
signal-regulated kinase  1/2 (ERK1/2) 
phosphorylation, stimulated expression of 
hepatocyte growth factor (HGF), and 
downregulated the expression of tumor 
suppressor gene CDKN2A.57 MCF-10A cells 
treated with a combination of NNK and 
benzo[a]pyrene (B[a]P) induced breast 
cancer carcinogenesis through DNA 
damage, Ras-ERK-Nox signalling activation, 
and reactive oxygen species elevation.58 By 
profiling gene expressions using cDNA 
microarray, NNK regulated several 
important breast cancer related genes 
including downregulation of PCSK2, 
TUBB2C, and S100A2 and upregulation of 
CRYAB, HSD11B2, FLJ20366 and 
TRIM29.59 In addition, NNK is capable of 
inducing malignant transformation of 
noncancerous breast epithelial cells, 
accompanied by a loss of responsiveness to 
17 β-estradiol via the ERK-dependent 
pathway.60 
Formation of DNA Adducts in Smoking 
Breast Cancer Patients 
Cigarette smoke is known to cause DNA 
adducts and mutations inducing tumor 
growth in humans.61 DNA adduct formation 
is considered as a critical step during tumor 
initiation. Among smokers who were 
passively exposed to second-hand smoke, 
electrophilic metabolic forms of tobacco 
components were detected in breast 
epithelial cells, which bound to DNA and 
formed DNA adducts.62 This phenomena is 
shown in both cancerous and normal breast 
tissue. Evidence showed that mutagens 
including prochlorperazine from exogenous 
sources were detected in the breast fluid of 
postmenopausal women. Also, cigarette-
induced DNA adducts were identified in 
normal breast tissues in smokers with breast 
cancer. Smokers had a higher prevalence of 
TP53 mutations than non-smokers.49 The 
benzopyrene caused genomic alteration in 
breast epithelial cells following exposure to 
smoking showed similar levels with those 
seen in familial breast cancer cells. The 
action of cytochrome P450 plays an 
important role in NNK metabolism to form N-
nitrosonornicotine (NNN) and 4-
(methylnitrosamino)- 1-(3-pyridyl)-1-butanol 
(NNAL). These metabolites induce 
pyridylhydroxybutylation, 
pyridyloxobutylation, and methylation of 
nucleobases inside the nucleus. 
Subsequently, NNK metabolites bind to DNA 
and change into the covalent binding forms 
named DNA adducts.63 
Progression of NNK Mediated Signaling 
Pathways in Smoking Breast Cancer 
Patients 
Smoke components have been proven to 
cause DNA alteration through various 
signaling pathways (Figure 2).22 As NNK is 
an agonist for nAChRs, most of the effects 
are mediated by the binding to nAChRs, 
such as α9- or α7-nAChRs, to cause 
proliferation, apoptosis, migration, invasion, 
angiogenesis, and chemoresistance. NNK 
activates the protein kinase C (PKC), 
ERK1/2, protein kinase A (PKA), or protein 
kinase B (Akt) pathways, or activates Bcl-2, 
Mcl-1, and c-Myc, or suppresses Bad and 
Bax, to induce proliferation and apoptosis.64 
On the other hand, activation of ERK 
activates calpains and suppresses E-
cadherin, β-catenin, or ZO-1 to promote 
migration. NNK increases the influx of Ca2+ 
to activate PKA, vascular endothelial growth 
factor (VEGF), and fibroblast growth factor 2 
(FGF2) for angiogenesis in smoking breast 
cancer patients.65 
Conclusion and Future Perspectives 
Although carcinoma of the breast affects a 
region other than the mouth, it causes 
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several problems at the oral level. It may act 
in a direct way by weakening the immune 
system, and thereby increasing the risk of 
developing periodontal disease. Breast 
cancer therapy also has different effects on 
the oral cavity that the periodontist must 
know. From this review, we can clearly 
understand the relationship between 
periodontal disease and smokers’ breast 
cancer, thereby raising our awareness of the 
importance of oral health maintenance, 
which may lead to a reduced risk of 
developing breast cancer. 
Frequent professional oral hygiene 
sessions can reduce the risk of developing 
periodontal disease and with the use of 
artificial saliva and a diet low in fermentable 
sugars risk of caries can be reduced.66 
Patients undergoing hormone therapy may 
have bone loss, and a periodontist must 
know this possibility and monitor the 
condition by assessing the possible need for 
anti-osteoporosis therapy.67 Chemotherapy 
modifies the oral microbiome of the patient 
and an assessment of the cariogenic 
species through appropriate instrumental 
tests can be performed periodically to 
investigate these bacteria early before signs 
of caries begin to appear.66 Periodontists 
should be aware of these disorders resulting 
from the therapy of breast cancer in order to 
inform patients about any alterations they 
might have. As regards to periodontal 
disease, most researchers who have 
investigated the correlation with breast 
cancer have also mentioned that better 
conducted studies would be needed with 
comparable and standardized protocols 
along with more accurate sampling methods. 
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